Inhibrx Biosciences INBX

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: Biological Products, (No Diagnostic Substances)
Headquarters: La Jolla, California
Fiscal year end: 12/31
Next earnings: 11/12, estimated

No member of Congress reported a trade in Inhibrx Biosciences INBX in the past 90 days. Insiders filed 5 purchases and 0 sales on the open market over the same period, a net purchase of $1.5M.

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: +$1.5M; Last 90 days · bought $1.5M · sold $0
Next earnings: 11/12; Estimated from the last four quarters

26-week trading

Common questions

Did Inhibrx Biosciences INBX insiders buy or sell in the past 90 days?: In the past 90 days insiders filed 5 purchases and 0 sales on the open market. Purchases came to $1.5M.